Guarente, L. (2000). Sir2 links chromatin silencing,metabolism, and
aging. Genes Dev. 14, 1021-1026.

Hanahan, D.,and Weinberg, R.A. (2000). The hallmarks of cancer. Cell
100, 57-70:.

Harikrishnan,K.N., Chow, M.Z., Baker, E.K., Pal, S., Bassal, S., Brasacchio, D.,, Wang, L.,, Craig, Ð¡ M., Jones, P.L., Sif, S., and EI-Osta,
A. (2005). Brahma links the SWMSNF chromatin-remodeling complex
with MeCP2-dependent transcriptional silencing.¡¢Nat:Genet.37,
254-~-264.

Janzen,V., Forkert, R., Fleming, H.E., Saito,Y., Waring, M.T.,, Dombkowski, D.M., Cheng, T.,, DePinho, R.A., Sharpless, N.E., and Scadden, D.T. (2006). Stem-cell ageing modified by the cyclin-dependent
kinase inhibitor p16INK4a. Nature 443, 421-~426.

Jenuwein, T. (2006). The epigenetic magic of histone lysine methylation. FEBS J 273, 3121-~3135.

Jones, P.A., and Taylor, S.M. (1980). Cellular differentiation, cytidine
analogs and DNA methylation. Cel| 20, 85-93.

Jones, P.A.,and Laird, P.W. (1999). Cancer epigenetics comes of age.
Nat. Genet. 217, 163-~167.

Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428.

Jones, P.L.,Veenstra, GJ,Wade,P.A.,Vermaak,D.,KasSs,S.U.,
Landsberger, N,, Strouboulis, J,, and Wolffe, A.P. (1998). Methylated
DNA and MeCP2 recruit histone deacetylase to repress transcription.
Nat. Genet. 19, 187-~191.

Karpf,A.R.,Peterson,P.W.,Rawlins, JT.,Dalley,B.K.,Yang,Q.,
Albertsen, H.,and Jones, D.A. (1999). Inhibition ofDNAmethyltransferase stimulates the expression of signal transducer and activator of
transcription , 2, and 3 genes in colon tumor cells. Proc. Natl. Acad .
Sci. USA 96, 14007-~14012.

Kimura, A., Umehara, T,and Horikoshi,M. (2002).Chromosomal
gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat. Genet. 32, 370-377.

Kinzler, K.W.,and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-~170.

Kiyono, T, Foster, S.A,, Koop, J.l, McDougallh J.K.,, Galloway, D.A.,
and Klingelhutz,AJ¡¢(1998),¡¢Both Rb/p16INK4a inactivation and
telomerase activity are required to immortalize human epithelial cells.
Nature 396, 84-~88.

Knoepfler, P.S., Zhang, X.Y., Cheng, P.F., Gafken, P.R., McMahon,
S.B., and Eisenman,R.N. (2006). Myc influences global chromatin
structure. EMBO J 25, 2723-~2734.

Krishnamurthy, J, Ramsey,M.R., Ligon,K.L., Torrice,C.,Koh, A.,
Bonner-Weir, S., and SharplesSs, N.E. (2006). p16INK4a induces an
age-dependent decline in islet regenerative potential.Nature 443,
453-~457.

Kuzmichev,A.u,Margueron, R.,Vaquero, A., Preissner,T.S., Scher, M.,
Kirmizis, A., Ouyang, X.,, Brockdorff, N.,, Abate-Shen, C., Farnham, P.,
and Reinberg, D. (2005). Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc. Natl. Acad. Sci. USA 102, 1859-~1864.

Laverriere,A.C., MacNeil C., Mueller,C., Poelmann, R.E., Burch,J.B.,
and Evans, T. (1994). GATA-4/5/6, a subfamily of three transcription
factors transcribed in developing heart and gut. J Biol. Chem. 269,
23177-~23184.

Lee, T.|,Jenner,R.G.,Boyer, L.A.,Guenther,M.G.,Levine,S.S.,
Kumar, R.M., Chevalier, B., Johnstone, S.E:,Cole,M.F., ISono,K.,
et al. (2006). Control of developmental regulators by Polycomb in
human embryonic stem cells. Cell 125, 301-313.

Lib, H., in, S., Wang, W., Duncan, E.M., Wysocka, J., Allis, C.D.,, and
Patel, D.J. (2006). Molecular basis for site-specific read-out of histone
H3K4me3 by the BPTF PHD finger of NURF. Nature 442, 91-95.

Liang, G., Gonzales, F.A.,, Jones, P.A., Orntoft, T.F., and Thykjaer, T
(2002). Analysis of gene induction in human fibroblasts and bladder
cancer cells exposed to the methylation inhibitor 5-aza-2¡¸-deoxycytidine. Cancer Res. 62, 961-~966.

Lu,H.,Ouyang, W.,and Huang, C. (2006). Inflammation,a key event in
cancer development. Mol. Cancer Res. 4, 221-233.

Marks,P.,,Rifkind, R.A.,Richon,V.M., Breslow,R., Miller, T., and Kelly,
W.K. (2001). Histone deacetylases and cancer: causes and therapies:.
Nat. Rev. Cancer , 194-~202.

McDermott,K.M.,Zhang,J., Holst, C.R., Kozakiewicz, B.K., Singla, V.,
and Tlsty, T.D. (2006). p16(INK4a) prevents centrosome dysfunction
and genomic instability in primary cells. PLoS Biol. 4, e51.

McGarvey, K.M., Fahrner, J.A., Greene, E., Martens, J., Jenuwein, T.,
and Baylin, S.B. (2006). Silenced tumor suppressor genes reactivated
by DNA demethylation do not return to a fully euchromatic chromatin
state. Cancer Res. 66, 3541-~3549.

Minuccib, S., and Pelicci, P.G. (2006). Histone deacetylase inhibitors
and the promise of epigenetic (and more) treatments for cancer. Nat.
Rev. Cancer 6, 38-51.

Molkentin,J.D.,Lin,Q.,Duncan, S.A.,,and Olson, E.N. (1997). Requirement of the transcription factor GATA4 for heart tube formation and
ventral morphogenesis. Genes Dev. 11, 1061-1072.

Molofsky, A.V., SlIlutsky, S.G., Joseph, N.M., He, S.,, Pardal, R., Krishnamurthy, J,, Sharpless, N.E.,, and Morrison, S.J. (2006). Increasing
p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452.

Nan, X.,, Ng, H.H., Johnson, C.A.J, Laherty, C.D., Turner, B.M., Eisenman,R.N.,and Bird, A.(1998). Transcriptional repression by the
methyl-CpG-binding protein MeCP2 involves a histone deacetylase
complex. Nature 393, 386-389.

Nelson,W.G.,De Marzo,A.M.,DeWeese, T.L.,and IlsaacSs,W.B.
(2004). The role of inflammation in the pathogenesis of prostate cancer. J Urol. I72, S6-~-S12.

Orlando,V. (2003). Polycomb, epigenomes, and control of cellidentity.
Cell 112, 599-~606.

Pirrotta,V., and Gross, D.S. (2005). Epigenetic silencing mechanisms
in budding yeast and fruit fly: different paths, same destinations.
Mol. Cell 18, 395-398.

Pruitt, K., Zinn,R.L., Ohm,J.E., McGarvey, K.M., Kang, S.H., Watkins,
D.N.,, Herman,J.G., and Baylin, 3.B. (2006). Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2, e40.

Reynolds, P.A., Sigaroudinia, M., Zardo, G.,Wilson, M.B.,Benton,
G.M.,Miller,CJ., Hong,C., Fridlyand, J,Costello, J.F., and Tlsty,
T.D. (2006). Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells.
J Biol. Chem. 281, 24790-~-24802.

Riggs, A.D.,, and Jones, P.A. (1983). 5-methylcytosine, gene regulation, and cancer. Adv. Cancer Res. 40, 1-30.

Ringrose, L., and Paro, R. (2004).Epigenetic regulation of cellular
memory by the Polycomb and Trithorax group proteins. Annu. Rev.
Genet. 38, 413-~443.

Roberts, C.W., and Orkin, S.H. (2004). The SWIMSNF complex-chromatin and cancer. Nat. Rev. Cancer 4, 133-~142.

Saito,}Y.,Liang, G., Egger,G.,Friedman,J.M., Chuang,,J.C., Coetzee,
G.A.,and Jones, P.A.(2006). Specific activation ofmicroRNA-127 with
downregulation of the proto-oncogene BCL6 by chromatin-modifying
drugs in human cancer cells. Cancer Cell 9, 435-443.

Santi, D.V., Garrett, C.E., and Barr, P.J. (1983). On the mechanism of
inhibition of DNA-cytosine methyltransferases by cytosine analogs.
Cel| 33, 9-10.

Schlesinger, Y., Straussman, R., Keshet, |,Farkash,S., Hecht,M.,
Zimmerman, J Eden, E:,Yakhini, Z., Ben-Shushan,E.,Reubinoff,

Cell 128, 683-692, February 23, 2007 @2007 Elsevier Inc.¡£ 691
